Joseph C. Galante, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 1,623 shares at $1.95 ($3K) on 2022-06-16, disclosed to the SEC on 2022-07-01.
Scheduled purchase ($3k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.05 | 76 | $156 | 4.7% |
| 2 | $2.08 | 76 | $158 | 4.8% |
| 3 | $2.09 | 76 | $159 | 4.8% |
| 4 | $2.07 | 81 | $168 | 5.1% |
| 5 | $2.08 | 60 | $125 | 3.8% |
| 6 | $2.12 | 81 |
| $172 |
| 5.2% |
| 7 | $2.09 | 81 | $169 | 5.1% |
| 8 | $2.04 | 81 | $165 | 5.0% |
| 9 | $2.01 | 81 | $163 | 4.9% |
| 10 | $2.02 | 81 | $164 | 4.9% |
| 11 | $1.98 | 81 | $160 | 4.8% |
| 12 | $1.95 | 81 | $158 | 4.8% |
| 13 | $1.94 | 81 | $157 | 4.7% |
| 14 | $1.97 | 86 | $169 | 5.1% |
| 15 | $1.99 | 82 | $163 | 4.9% |
| 16 | $2.01 | 86 | $173 | 5.2% |
| 17 | $2.11 | 86 | $181 | 5.5% |
| 18 | $2.06 | 15 | $31 | 0.9% |
| 19 | $2.06 | 79 | $163 | 4.9% |
| 20 | $2.11 | 86 | $181 | 5.5% |
| 21 | $2.08 | 86 | $179 | 5.4% |
| Total | $2.04 avg | 1,623 | $3K | 100% |
| Filing → |
| CPIX | BUY | 2022-12-23 | $3K | — | Filing → |
| CPIX | BUY | 2022-11-18 | $4K | — | Filing → |
| CPIX | BUY | 2022-09-30 | $5K | — | Filing → |